Record Index Results
Search
Contents
Download
Documentation
About MassBank
News Archive
Index Type :
MS Type:
MS2
Back to Record Index
Results :
96,350 Hit.
( 40,686 - 40,933 Displayed )
First
Prev
188
189
190
191
192
193
194
195
196
197
Next
Last
( Total
439
Page )
▼
Results End
Name
Formula / Structure
ExactMass
ID
EP_M424
4 spectra
C17H13ClFN3O5S
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
425.02481
LC-ESI-QFT; MS2; CE: 20; R=35000; [M-H]-
MSBNK-Eawag_Additional_Specs-ET220551
LC-ESI-QFT; MS2; CE: 30; R=35000; [M-H]-
MSBNK-Eawag_Additional_Specs-ET220552
LC-ESI-QFT; MS2; CE: 40; R=35000; [M-H]-
MSBNK-Eawag_Additional_Specs-ET220553
LC-ESI-QFT; MS2; CE: 60; R=35000; [M-H]-
MSBNK-Eawag_Additional_Specs-ET220554
EP_M449
4 spectra
C20H18ClFN4O3S
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
448.07721
LC-ESI-QFT; MS2; CE: 20; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220201
LC-ESI-QFT; MS2; CE: 30; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220202
LC-ESI-QFT; MS2; CE: 40; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220203
LC-ESI-QFT; MS2; CE: 60; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220204
EP_M451
4 spectra
C20H20ClFN4O3S
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
450.09290
LC-ESI-QFT; MS2; CE: 20; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220301
LC-ESI-QFT; MS2; CE: 30; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220302
LC-ESI-QFT; MS2; CE: 40; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220303
LC-ESI-QFT; MS2; CE: 60; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220304
EP_M467
1 spectrum
C20H20ClFN4O4S
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
466.08780
LC-ESI-QFT; MS2; CE: 15; R=70000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220401
EP_M637
5 spectra
C27H30ClFN6O7S
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
636.15692
LC-ESI-QFT; MS2; CE: 20; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220601
LC-ESI-QFT; MS2; CE: 40; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220602
LC-ESI-QFT; MS2; CE: 60; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220603
LC-ESI-QFT; MS2; CE: 80; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220604
LC-ESI-QFT; MS2; CE: 90; R=35000; [M+H]+
MSBNK-Eawag_Additional_Specs-ET220605
EPA
1 spectrum
C20H30O2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
302.22458
LC-ESI-QQ; MS2; Negative; [M-H]-
MSBNK-MSSJ-MSJ00051
EPA-[d5]
6 spectra
C20H30O2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
302.22458
LC-ESI-QFT; MS2; CE: 20.0; R=30.000; [M-H]-
MSBNK-ISAS_Dortmund-IA000019
LC-ESI-QFT; MS2; CE: 30.0; R=30.000; [M-H]-
MSBNK-ISAS_Dortmund-IA000020
LC-ESI-QFT; MS2; CE: 40.0; R=30.000; [M-H]-
MSBNK-ISAS_Dortmund-IA000021
LC-ESI-QTOF; MS2; CE: 10.0; R=N/A; [M-H]-
MSBNK-ISAS_Dortmund-IA000400
LC-ESI-QTOF; MS2; CE: 20.0; R=N/A; [M-H]-
MSBNK-ISAS_Dortmund-IA000401
LC-ESI-QTOF; MS2; CE: 30.0; R=N/A; [M-H]-
MSBNK-ISAS_Dortmund-IA000402
Ephedrine
19 spectra
C10H15NO
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
165.11540
LC-ESI-ITFT; MS2; CE: 15%; R=15000; [M+H]+
MSBNK-Eawag-EA275808
LC-ESI-ITFT; MS2; CE: 15%; R=7500; [M+H]+
MSBNK-Eawag-EA275802
LC-ESI-ITFT; MS2; CE: 30%; R=15000; [M+H]+
MSBNK-Eawag-EA275809
LC-ESI-ITFT; MS2; CE: 30%; R=7500; [M+H]+
MSBNK-Eawag-EA275803
LC-ESI-ITFT; MS2; CE: 35%; R=30000; [M+H]+
MSBNK-Eawag-EA275814
LC-ESI-ITFT; MS2; CE: 35%; R=7500; [M+H]+
MSBNK-Eawag-EA275801
LC-ESI-ITFT; MS2; CE: 45%; R=15000; [M+H]+
MSBNK-Eawag-EA275810
LC-ESI-ITFT; MS2; CE: 45%; R=7500; [M+H]+
MSBNK-Eawag-EA275804
LC-ESI-ITFT; MS2; CE: 60%; R=15000; [M+H]+
MSBNK-Eawag-EA275811
LC-ESI-ITFT; MS2; CE: 60%; R=7500; [M+H]+
MSBNK-Eawag-EA275805
LC-ESI-ITFT; MS2; CE: 75%; R=15000; [M+H]+
MSBNK-Eawag-EA275812
LC-ESI-ITFT; MS2; CE: 75%; R=7500; [M+H]+
MSBNK-Eawag-EA275806
LC-ESI-ITFT; MS2; CE: 90%; R=30000; [M+H]+
MSBNK-Eawag-EA275813
LC-ESI-ITFT; MS2; CE: 90%; R=7500; [M+H]+
MSBNK-Eawag-EA275807
LC-ESI-QTOF; MS2; CE:10 eV; [M+H]+
MSBNK-Univ_Connecticut-CO000166
LC-ESI-QTOF; MS2; CE:20 eV; [M+H]+
MSBNK-Univ_Connecticut-CO000167
LC-ESI-QTOF; MS2; CE:30 eV; [M+H]+
MSBNK-Univ_Connecticut-CO000168
LC-ESI-QTOF; MS2; CE:40 eV; [M+H]+
MSBNK-Univ_Connecticut-CO000169
LC-ESI-QTOF; MS2; CE:50 eV; [M+H]+
MSBNK-Univ_Connecticut-CO000170
Epiandrosterone
21 spectra
C19H30O2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
290.22458
LC-APPI-QQ; MS2; CE:10 V; [M-2H2O+H]+
MSBNK-PFOS_research_group-FFF00191
LC-APPI-QQ; MS2; CE:10 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00185
LC-APPI-QQ; MS2; CE:20 V; [M-2H2O+H]+
MSBNK-PFOS_research_group-FFF00190
LC-APPI-QQ; MS2; CE:20 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00184
LC-APPI-QQ; MS2; CE:30 V; [M-2H2O+H]+
MSBNK-PFOS_research_group-FFF00189
LC-APPI-QQ; MS2; CE:30 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00183
LC-APPI-QQ; MS2; CE:40 V; [M-2H2O+H]+
MSBNK-PFOS_research_group-FFF00188
LC-APPI-QQ; MS2; CE:40 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00182
LC-APPI-QQ; MS2; CE:50 V; [M-2H2O+H]+
MSBNK-PFOS_research_group-FFF00187
LC-APPI-QQ; MS2; CE:50 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00181
LC-APPI-QQ; MS2; CE:60 V; [M-2H2O+H]+
MSBNK-PFOS_research_group-FFF00186
LC-APPI-QQ; MS2; CE:60 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00180
LC-ESI-ITFT; MS2; CE: 35; R=15000; [M+H]+
MSBNK-UFZ-UF416803
LC-ESI-ITFT; MS2; CE: 55; R=15000; [M+H]+
MSBNK-UFZ-UF416801
LC-ESI-ITFT; MS2; CE: 55; R=15000; [M+H]+
MSBNK-UFZ-UF416804
LC-ESI-QTOF; MS2; CE: 10 eV; R=35000; [M+H]+
MSBNK-Athens_Univ-AU281801
LC-ESI-QTOF; MS2; CE: 20 eV; R=35000; [M+H]+
MSBNK-Athens_Univ-AU281802
LC-ESI-QTOF; MS2; CE: 30 eV; R=35000; [M+H]+
MSBNK-Athens_Univ-AU281803
LC-ESI-QTOF; MS2; CE: 40 eV; R=35000; [M+H]+
MSBNK-Athens_Univ-AU281804
LC-ESI-QTOF; MS2; CE: 50 eV; R=35000; [M+H]+
MSBNK-Athens_Univ-AU281805
LC-ESI-QTOF; MS2; CE: Ramp 21.3-31.9 eV; R=35000; [M+H]+
MSBNK-Athens_Univ-AU281806
Epicatechin
7 spectra
C15H14O6
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
290.07901
LC-ESI-QTOF; MS2; CE:10 eV; [M-H]-
MSBNK-BS-BS003426
LC-ESI-QTOF; MS2; CE:15 eV; [M+H]+
MSBNK-IPB_Halle-PB001337
LC-ESI-QTOF; MS2; CE:20 eV; [M-H]-
MSBNK-BS-BS003424
LC-ESI-QTOF; MS2; CE:25 eV; [M+H]+
MSBNK-IPB_Halle-PB001338
LC-ESI-QTOF; MS2; CE:40 eV; [M+H]+
MSBNK-IPB_Halle-PB001339
LC-ESI-QTOF; MS2; CE:55 eV; [M+H]+
MSBNK-IPB_Halle-PB001340
epicatechin
4 spectra
C15H14O6
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
290.27521
LC-ESI-QQQ; MS2; Frag=135.0V CID@10.0; [M+H]+
MSBNK-RIKEN_NPDepo-NGA02846
LC-ESI-QQQ; MS2; Frag=135.0V CID@15.0; [M+H]+
MSBNK-RIKEN_NPDepo-NGA02847
LC-ESI-QQQ; MS2; Frag=135.0V CID@25.0; [M+H]+
MSBNK-RIKEN_NPDepo-NGA02848
LC-ESI-QQQ; MS2; Frag=135.0V CID@5.0; [M+H]+
MSBNK-RIKEN_NPDepo-NGA02845
Epicatechin
7 spectra
C15H14O6
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
290.27100
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PM000405
Epicatechin-(4.beta.--8)epicatechin-(4.beta.--8)ep...
5 spectra
C45H38O18
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
866.78101
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PS120701
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PS120702
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PS120707
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PS120708
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PS120709
Epicholestanol
6 spectra
C27H48O
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
388.37051
LC-APPI-QQ; MS2; CE:10 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00157
LC-APPI-QQ; MS2; CE:20 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00156
LC-APPI-QQ; MS2; CE:30 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00155
LC-APPI-QQ; MS2; CE:40 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00154
LC-APPI-QQ; MS2; CE:50 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00153
LC-APPI-QQ; MS2; CE:60 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00152
Epicoprostanol
6 spectra
C27H48O
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
388.37051
LC-APPI-QQ; MS2; CE:10 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00021
LC-APPI-QQ; MS2; CE:20 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00020
LC-APPI-QQ; MS2; CE:30 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00019
LC-APPI-QQ; MS2; CE:40 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00018
LC-APPI-QQ; MS2; CE:50 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00017
LC-APPI-QQ; MS2; CE:60 V; [M-H2O+H]+
MSBNK-PFOS_research_group-FFF00016
Epiequisetin
12 spectra
C22H31NO4
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
373.22531
LC-ESI-ITFT; MS2; CE: 15%; R=7500; [M+H]+
MSBNK-HBM4EU-HB003564
LC-ESI-ITFT; MS2; CE: 15%; R=7500; [M-H]-
MSBNK-HBM4EU-HB003039
LC-ESI-ITFT; MS2; CE: 20%; R=7500; [M+H]+
MSBNK-HBM4EU-HB003565
LC-ESI-ITFT; MS2; CE: 20%; R=7500; [M-H]-
MSBNK-HBM4EU-HB003040
LC-ESI-ITFT; MS2; CE: 30%; R=7500; [M+H]+
MSBNK-HBM4EU-HB003566
LC-ESI-ITFT; MS2; CE: 30%; R=7500; [M-H]-
MSBNK-HBM4EU-HB003041
LC-ESI-ITFT; MS2; CE: 40%; R=7500; [M+H]+
MSBNK-HBM4EU-HB003567
LC-ESI-ITFT; MS2; CE: 40%; R=7500; [M-H]-
MSBNK-HBM4EU-HB003042
LC-ESI-ITFT; MS2; CE: 50%; R=7500; [M+H]+
MSBNK-HBM4EU-HB003568
LC-ESI-ITFT; MS2; CE: 50%; R=7500; [M-H]-
MSBNK-HBM4EU-HB003043
LC-ESI-ITFT; MS2; CE: 60%; R=7500; [M+H]+
MSBNK-HBM4EU-HB003569
LC-ESI-ITFT; MS2; CE: 60%; R=7500; [M-H]-
MSBNK-HBM4EU-HB003044
Epigallocatechin
52 spectra
C15H14O7
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
306.07401
LC-ESI-ITFT; MS2; CE: 100%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001769
LC-ESI-ITFT; MS2; CE: 105%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001896
LC-ESI-ITFT; MS2; CE: 105%; R=15000; [M+H]+
MSBNK-NaToxAq-NA002125
LC-ESI-ITFT; MS2; CE: 110%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001771
LC-ESI-ITFT; MS2; CE: 115%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001898
LC-ESI-ITFT; MS2; CE: 115%; R=15000; [M+H]+
MSBNK-NaToxAq-NA002127
LC-ESI-ITFT; MS2; CE: 120%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001773
LC-ESI-ITFT; MS2; CE: 125%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001900
LC-ESI-ITFT; MS2; CE: 125%; R=15000; [M+H]+
MSBNK-NaToxAq-NA002129
LC-ESI-ITFT; MS2; CE: 15%; R=15000; [M+H]+
MSBNK-NaToxAq-NA000883
LC-ESI-ITFT; MS2; CE: 15%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001013
LC-ESI-ITFT; MS2; CE: 20%; R=15000; [M+H]+
MSBNK-NaToxAq-NA000884
LC-ESI-ITFT; MS2; CE: 20%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001014
LC-ESI-ITFT; MS2; CE: 25%; R=15000; [M+H]+
MSBNK-NaToxAq-NA000885
LC-ESI-ITFT; MS2; CE: 25%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001015
LC-ESI-ITFT; MS2; CE: 30%; R=15000; [M+H]+
MSBNK-NaToxAq-NA000886
LC-ESI-ITFT; MS2; CE: 30%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001016
LC-ESI-ITFT; MS2; CE: 35%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001017
LC-ESI-ITFT; MS2; CE: 35%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001138
LC-ESI-ITFT; MS2; CE: 40%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001137
LC-ESI-ITFT; MS2; CE: 40%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001260
LC-ESI-ITFT; MS2; CE: 45%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001140
LC-ESI-ITFT; MS2; CE: 45%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001259
LC-ESI-ITFT; MS2; CE: 50%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001139
LC-ESI-ITFT; MS2; CE: 50%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001262
LC-ESI-ITFT; MS2; CE: 55%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001261
LC-ESI-ITFT; MS2; CE: 55%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001390
LC-ESI-ITFT; MS2; CE: 55%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001515
LC-ESI-ITFT; MS2; CE: 60%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001141
LC-ESI-ITFT; MS2; CE: 60%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001650
LC-ESI-ITFT; MS2; CE: 65%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001263
LC-ESI-ITFT; MS2; CE: 65%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001392
LC-ESI-ITFT; MS2; CE: 65%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001517
LC-ESI-ITFT; MS2; CE: 70%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001389
LC-ESI-ITFT; MS2; CE: 70%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001514
LC-ESI-ITFT; MS2; CE: 70%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001652
LC-ESI-ITFT; MS2; CE: 75%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001649
LC-ESI-ITFT; MS2; CE: 75%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001770
LC-ESI-ITFT; MS2; CE: 80%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001391
LC-ESI-ITFT; MS2; CE: 80%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001516
LC-ESI-ITFT; MS2; CE: 80%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001897
LC-ESI-ITFT; MS2; CE: 80%; R=15000; [M+H]+
MSBNK-NaToxAq-NA002126
LC-ESI-ITFT; MS2; CE: 85%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001651
LC-ESI-ITFT; MS2; CE: 85%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001772
LC-ESI-ITFT; MS2; CE: 90%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001393
LC-ESI-ITFT; MS2; CE: 90%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001518
LC-ESI-ITFT; MS2; CE: 90%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001899
LC-ESI-ITFT; MS2; CE: 90%; R=15000; [M+H]+
MSBNK-NaToxAq-NA002128
LC-ESI-ITFT; MS2; CE: 95%; R=15000; [M+H]+
MSBNK-NaToxAq-NA001653
LC-ESI-QTOF; MS2; CE:10 eV; [M-H]-
MSBNK-BS-BS003949
LC-ESI-QTOF; MS2; CE:20 eV; [M-H]-
MSBNK-BS-BS003952
LC-ESI-QTOF; MS2; CE:30 eV; [M-H]-
MSBNK-BS-BS003950
Epigallocatechin gallate
5 spectra
C22H18O11
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
458.08490
LC-ESI-QTOF; MS2; CE:10 eV; [M-H]-
MSBNK-BS-BS003896
LC-ESI-QTOF; MS2; CE:20 eV; [M-H]-
MSBNK-BS-BS003899
LC-ESI-QTOF; MS2; CE:30 eV; [M-H]-
MSBNK-BS-BS003901
LC-ESI-QTOF; MS2; CE:40 eV; [M-H]-
MSBNK-BS-BS003897
LC-ESI-QTOF; MS2; CE:50 eV; [M-H]-
MSBNK-BS-BS003900
Epigallocatechin-3-gallate
26 spectra
C22H18O11
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
458.08490
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302550
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302556
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302562
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302568
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302574
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302580
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302586
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302592
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302598
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302604
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302610
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR302616
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306209
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306215
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306221
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306227
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306233
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306239
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306245
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306251
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306257
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306263
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306269
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR306275
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR308799
LC-ESI-QTOF; MS2
MSBNK-RIKEN-PR310494
Epihesperidin
1 spectrum
C28H34O15
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
610.18976
LC-ESI-ITTOF; MS2; [M-H]-
MSBNK-Univ_Toyama-TY000205
Epinephrine
15 spectra
C9H13NO3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
183.08954
LC-ESI-QFT; MS2; CE: 15; R=35000; [M+H]+
MSBNK-Eawag-EQ332501
LC-ESI-QFT; MS2; CE: 15; R=35000; [M-H]-
MSBNK-Eawag-EQ332551
LC-ESI-QFT; MS2; CE: 30; R=35000; [M+H]+
MSBNK-Eawag-EQ332502
LC-ESI-QFT; MS2; CE: 30; R=35000; [M-H]-
MSBNK-Eawag-EQ332552
LC-ESI-QFT; MS2; CE: 45; R=35000; [M+H]+
MSBNK-Eawag-EQ332503
LC-ESI-QFT; MS2; CE: 45; R=35000; [M-H]-
MSBNK-Eawag-EQ332553
LC-ESI-QFT; MS2; CE: 60; R=35000; [M+H]+
MSBNK-Eawag-EQ332504
LC-ESI-QFT; MS2; CE: 60; R=35000; [M-H]-
MSBNK-Eawag-EQ332554
LC-ESI-QFT; MS2; CE: 75; R=35000; [M+H]+
MSBNK-Eawag-EQ332505
LC-ESI-QFT; MS2; CE: 75; R=35000; [M-H]-
MSBNK-Eawag-EQ332555
LC-ESI-QFT; MS2; CE: 90; R=35000; [M+H]+
MSBNK-Eawag-EQ332506
LC-ESI-QFT; MS2; CE: 90; R=35000; [M-H]-
MSBNK-Eawag-EQ332556
LC-ESI-QTOF; MS2; CE 10 ev; [M+H]+
MSBNK-Washington_State_Univ-BML01112
LC-ESI-QTOF; MS2; CE 10 ev; [M-H]-
MSBNK-Washington_State_Univ-BML01158
LC-ESI-QTOF; MS2; CE 20 ev; [M-H]-
MSBNK-Washington_State_Univ-BML01167
Epinine
5 spectra
C9H13NO2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
167.09464
LC-ESI-QQ; MS2; CE:10 V; [M+H]+
MSBNK-Keio_Univ-KO002839
LC-ESI-QQ; MS2; CE:20 V; [M+H]+
MSBNK-Keio_Univ-KO002840
LC-ESI-QQ; MS2; CE:30 V; [M+H]+
MSBNK-Keio_Univ-KO002841
LC-ESI-QQ; MS2; CE:40 V; [M+H]+
MSBNK-Keio_Univ-KO002842
LC-ESI-QQ; MS2; CE:50 V; [M+H]+
MSBNK-Keio_Univ-KO002843
Epiporogoitrin, R-2-hydroxy-3-butenyl glucosinolat...
3 spectra
C11H19NO10S2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
389.39999
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PS051107
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PS051108
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PS051112
Epiprogoitrin, (S)--2-Hydroxy-3-butenyl-glucosinol...
2 spectra
C11H19NO10S2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
389.39999
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PS107207
LC-ESI-QQ; MS2
MSBNK-RIKEN_ReSpect-PS107208
Epiprogoitrin, (S)--2-Hydroxy-3-butenyl-glucosinol...
2 spectra
C11H19NO10S2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
389.39999
LC-ESI-QTOF; MS2
MSBNK-RIKEN_ReSpect-PT110720
LC-ESI-QTOF; MS2
MSBNK-RIKEN_ReSpect-PT210720
Epirubicin
32 spectra
C27H29NO11
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
543.17407
LC-ESI-QTOF; MS2; 10 V
MSBNK-BAFG-CSL2311092331
LC-ESI-QTOF; MS2; 10 V
MSBNK-BAFG-CSL2311106496
LC-ESI-QTOF; MS2; 100 V
MSBNK-BAFG-CSL2311092330
LC-ESI-QTOF; MS2; 100 V
MSBNK-BAFG-CSL2311106494
LC-ESI-QTOF; MS2; 110 V
MSBNK-BAFG-CSL2311092333
LC-ESI-QTOF; MS2; 110 V
MSBNK-BAFG-CSL2311106503
LC-ESI-QTOF; MS2; 120 V
MSBNK-BAFG-CSL2311092320
LC-ESI-QTOF; MS2; 120 V
MSBNK-BAFG-CSL2311106507
LC-ESI-QTOF; MS2; 130 V
MSBNK-BAFG-CSL2311092332
LC-ESI-QTOF; MS2; 130 V
MSBNK-BAFG-CSL2311106493
LC-ESI-QTOF; MS2; 140 V
MSBNK-BAFG-CSL2311092335
LC-ESI-QTOF; MS2; 140 V
MSBNK-BAFG-CSL2311106498
LC-ESI-QTOF; MS2; 150 V
MSBNK-BAFG-CSL2311092325
LC-ESI-QTOF; MS2; 150 V
MSBNK-BAFG-CSL2311106499
LC-ESI-QTOF; MS2; 20 V
MSBNK-BAFG-CSL2311092334
LC-ESI-QTOF; MS2; 20 V
MSBNK-BAFG-CSL2311106497
LC-ESI-QTOF; MS2; 30 V
MSBNK-BAFG-CSL2311092328
LC-ESI-QTOF; MS2; 30 V
MSBNK-BAFG-CSL2311106502
LC-ESI-QTOF; MS2; 40 V
MSBNK-BAFG-CSL2311092323
LC-ESI-QTOF; MS2; 40 V
MSBNK-BAFG-CSL2311092327
LC-ESI-QTOF; MS2; 40 V
MSBNK-BAFG-CSL2311106505
LC-ESI-QTOF; MS2; 40 V
MSBNK-BAFG-CSL2311106506
LC-ESI-QTOF; MS2; 50 V
MSBNK-BAFG-CSL2311092322
LC-ESI-QTOF; MS2; 50 V
MSBNK-BAFG-CSL2311106504
LC-ESI-QTOF; MS2; 60 V
MSBNK-BAFG-CSL2311092321
LC-ESI-QTOF; MS2; 60 V
MSBNK-BAFG-CSL2311106495
LC-ESI-QTOF; MS2; 70 V
MSBNK-BAFG-CSL2311092329
LC-ESI-QTOF; MS2; 70 V
MSBNK-BAFG-CSL2311106500
LC-ESI-QTOF; MS2; 80 V
MSBNK-BAFG-CSL2311092324
LC-ESI-QTOF; MS2; 80 V
MSBNK-BAFG-CSL2311106508
LC-ESI-QTOF; MS2; 90 V
MSBNK-BAFG-CSL2311092326
LC-ESI-QTOF; MS2; 90 V
MSBNK-BAFG-CSL2311106501
First
Prev
188
189
190
191
192
193
194
195
196
197
Next
Last
( Total
439
Page )
▲
Results Top
Imprint
Feedback
system version 2.2.5
Copyright © 2006 MassBank Project; 2011
NORMAN Association
; 2021
MassBank Consortium
Responsible:
Hannes Bohring
Search
Contents
Download
Documentation
About MassBank
News Archive
